Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.
about
Hormone therapy in postmenopausal women and risk of endometrial hyperplasiaHormone therapy in postmenopausal women and risk of endometrial hyperplasiaHormone therapy in postmenopausal women and risk of endometrial hyperplasiaDesign and conduct of clinical trials in hormone replacement therapy.A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects.A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. I. An assessment of the quality of randomized trials published between 1977 and 1995.Low-dose hormone replacement therapy: effects on bone.Effects of progestins on bone: an update.Comparing therapies for postmenopausal osteoporosis prevention and treatment.Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogensHormone replacement therapy. Risks, benefits, and costs.Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women.Serum from postmenopausal women directs differentiation of human clonal osteoprogenitor cells from an osteoblastic toward an adipocytic phenotype.Prevention of fractures in the elderly. A review.Characterization of the stromal osteogenic cell line MN7: mRNA steady-state level of selected osteogenic markers depends on cell density and is influenced by 17 beta-estradiol.Use of estrogen for prevention and treatment of osteoporosis.Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women.Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.1 and 2 mg 17beta-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal women.Er-xian Decoction exerts estrogen-like osteoprotective effects in vivo and in vitro.Hormones, Estrogens and Antiestrogens
P2860
Q24201543-5D60C69A-40C8-4F81-B365-91F21035206DQ24241713-379934BC-0549-4490-B53F-D91149575197Q24246573-DC756EBF-F0E8-4C61-814C-D67C35A92FB9Q34397332-677BE60C-8C0F-4BF3-980F-7D6B17F2ECE0Q34573282-39AF1B77-85C3-4431-AAEA-4E856666412BQ34573300-54EA82A0-650E-49D7-B200-34D52452BE1AQ34672074-28025D74-5A7F-4D2C-9F24-838978E356AAQ34847643-B381D000-C5C0-4D1E-8F68-166EE51A0DDBQ35112397-15B4EBDB-92C3-4827-A027-AE4D97F340FDQ36086159-994D0EF7-B7F7-4CB1-BB66-DE3C499608FEQ36116123-E6F772B1-7716-45B0-A3EF-5C28FCF1E0B9Q36652768-1821208A-F18E-4F07-A0E3-BF9D884918B9Q39408968-1E7365E0-437D-4E4B-A014-7333BF170629Q40149967-7A61EFCB-73FB-4B77-B929-191D492E976AQ40597874-E9E9EFD8-6E97-4677-94BD-6846F11B0BE6Q41491087-89925E1D-9434-4E8F-ACFF-C778AF596A7CQ41533128-B0D31B09-32AD-43CB-A3FC-4C461C7B5B16Q44110990-5203A3DC-7562-4395-AB27-F9F56941540EQ44206843-A1D82495-ACA3-4DDD-9EBF-3A3F5584F134Q46646668-159C7B63-38B5-471F-AFB9-92E9D415BCC5Q46877678-46EF534A-715E-494D-A1C6-4740AC3C6B5BQ53071363-8E73D802-FFF8-4A0E-9F4E-7CD12AB818B2Q56031072-4FFA1A75-1C74-4A1F-9063-5415250F5B3B
P2860
Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.
@en
Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.
@nl
type
label
Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.
@en
Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.
@nl
prefLabel
Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.
@en
Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.
@nl
P2093
P1476
Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.
@en
P2093
P304
P356
10.1016/0002-9378(92)91653-R
P407
P577
1992-02-01T00:00:00Z